Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
Crossref DOI link: https://doi.org/10.1158/2326-6066.CIR-17-0258
Published Online: 2017-11-30
Published Print: 2017-12-01
Update policy: https://doi.org/10.1158/crossmark_policy
Wiehagen, Karla R.
Girgis, Natasha M.
Yamada, Douglas H.
Smith, Andressa A.
Chan, Szeman Ruby
Grewal, Iqbal S.
Quigley, Michael
Verona, Raluca I.
Funding for this research was provided by:
Janssen Research and Development (Janssen R&D)
